NOTE: This disposition is nonprecedential. United States Court of Appeals
for the Federal Circuit
SHILPA PHARMA, INC.,
Appellant
v.
NOVARTIS PHARMACEUTICALS CORPORATION,
Appellee
2024-1181
Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2022-00886.
JUDGMENT
MARK BOLAND, Sughrue Mion, PLLC, Washington, DC, argued for appellant. Also represented by MICHAEL R. DZWONCZYK, RAJA SALIBA.
WILLIAM M. JAY, Goodwin Procter LLP, Washington, DC, argued for appellee. Also represented by ELIZABETH A. KIERNAN, Gibson, Dunn & Crutcher LLP, Dallas, TX; JANE M. LOVE, ROBERT TRENCHARD, New York, NY.
2THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:
Judge, and BUMB, Chief District Judge ).
AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY ORDER OF THE COURT
July 10, 2025
Date